Fri, March 1, 2024

Joseph Pantginis Reiterated (CAPR) at Strong Buy and Held Target at $40 on, Mar 1st, 2024

Joseph Pantginis of HC Wainwright & Co., Reiterated "Capricor Therapeutics, Inc." (CAPR) at Strong Buy and Held Target at $40 on, Mar 1st, 2024.

Joseph has made no other calls on CAPR in the last 4 months.



There is 1 other peer that has a rating on CAPR. Out of the 1 peers that are also analyzing CAPR, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Kristen Kluska of "Cantor Fitzgerald" Initiated at Buy and Held Target at $8 on, Friday, January 5th, 2024